Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation
Authors
Keywords
-
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 39, Issue 3, Pages 239-253
Publisher
Wiley
Online
2013-12-06
DOI
10.1111/apt.12571
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Su2069 How Effective Is Prucalopride for the Treatment of Chronic Constipation? A Systematic Review and Meta-Analysis
- (2015) Luigi Gatta et al. GASTROENTEROLOGY
- Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation - a comparison in a controlled environment
- (2013) R. Cinca et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders
- (2012) J. Tack et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation
- (2012) Jan Tack et al. Expert Opinion on Drug Metabolism & Toxicology
- Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study
- (2012) M. Ke et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Prevalence of and Risk Factors for, Chronic Idiopathic Constipation in the Community: Systematic Review and Meta-analysis
- (2011) Nicole C Suares et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis
- (2011) A. C. Ford et al. GUT
- Inclusion criteria for pharmacodynamic and clinical trials in chronic idiopathic constipation: pitfalls in using Rome III for functional constipation
- (2011) Michael Camilleri Therapeutic Advances in Gastroenterology
- Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies
- (2010) M. Camilleri et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response study
- (2010) M. Goldberg et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Prucalopride for constipation
- (2010) Michael Camilleri et al. EXPERT OPINION ON PHARMACOTHERAPY
- 905 A Novel Gastrointestinal Prokinetic, ATI-7505, Increased Spontaneous Bowel Movements (Sbms) in a Phase II, Randomized, Placebo-Controlled Study of Patients With Chronic Idiopathic Constipation (CIC)
- (2010) Monica Palme et al. GASTROENTEROLOGY
- 5-HT4 receptor agonists: similar but not the same
- (2010) J. H. De Maeyer et al. NEUROGASTROENTEROLOGY AND MOTILITY
- A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation
- (2010) S. Müller-lissner et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study
- (2009) m. camilleri et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation - a 12-week, randomized, double-blind, placebo-controlled study
- (2008) E. M. M. QUIGLEY et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Why Most Discovered True Associations Are Inflated
- (2008) John P. A. Ioannidis EPIDEMIOLOGY
- Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives
- (2008) J Tack et al. GUT
- The in vitro pharmacological profile of TD-5108, a selective 5-HT4 receptor agonist with high intrinsic activity
- (2008) J. A. M. Smith et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- The in vivo gastrointestinal activity of TD-5108, a selective 5-HT4 receptor agonist with high intrinsic activity
- (2008) D. T. Beattie et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- A Placebo-Controlled Trial of Prucalopride for Severe Chronic Constipation
- (2008) Michael Camilleri et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started